Garnett has more than 25 years' experience in the marketing of healthcare products. Prior to starting Navicor, he was the Oncology Business Unit lead at GSW.
Prior to joining GSW Worldwide, Garnett was Vice President of Alliance Management, External Development at Bristol-Myers Squibb Company (BMS). During his 20 years with BMS, Garnett's experience spanned oncology marketing (including the US launch of Taxol®), oncology global marketing and strategic planning, oncology intercontinental franchise management, immunology/biologics franchise management, HIV (including the launch of Zerit®), women's healthcare, and infant formula marketing.
Garnett's lengthy and successful career in oncology marketing is highlighted by many significant achievements: he has overseen a number of product launches and relaunches, brought the world's first billion-dollar oncology drug to market, and transformed small pharmaceutical company divisions into industry powerhouses, to name a few examples. But perhaps more impressive than Garnett's résumé are the insights he's gained from his experience as a pharmaceutical marketer.
One of these insights, in fact, led him to recognize an unmet need in his own industry-a need for a communications company focused exclusively on the therapeutic areas of oncology and immunology. Thus, The Navicor Group was born.